Ledger.Open graph →
SEC Form D · filed December 12, 2012

Morria Biopharmaceuticals PLC

Offering
$1.5M
Sold
$1.5M
Exemption
—
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

People & firms on this filing (16)

David L. Potter · Tampa, FLDirectorNicola (Nick) Sanna · Spokane, WADirectorKerry Hatch · Boston, MAExec · DirectorDaniel Choi · Boston, MADirectorAmos Eiran · HERZELIYA, L3DirectorYuval Cohen · LONDON, United KingdomExec · DirectorDov Elefant · LONDON, United KingdomExecMark Cohen · NEW YORK, NYDirectorEliot Buchanan · Boston, MAExecRobert Dobbs · Tampa, FLExecAlan Harris · NEW YORK, NYExecPiney Point Capital GP LLC · Milwaukee, WIDirectorGilead Raday · KEFAR-URIA, L3DirectorMichail Medvinsky · Boston, MADirectorUri Foox · New York, NYExec · DirectorSaul Yedgar · JERUSALEM, L3Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗